Work

Abstract PS3-13-12: Parp inhibition augments response to anti-pd1 therapy in hrd mutated breast cancer

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps3-13-12

Authors: S. Chaudhuri, A. Emata, J. Camara Serrano, V. Steri, S. Thomas, P. Munster

Institution: University of California, San Francisco

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129651987

Cites:

Cited by:

Related to: